Angiogenic Cell Therapy

· Northern Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Angiogenic Cell Therapy, covering 2025-01-31 to 2025-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension [Phase 2, Phase 3]